UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant

The Journal of infectious diseases, 1999-10, Vol.180 (4), p.970-975

1999

Volltextzugriff (PDF)

Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial

JAMA : the journal of the American Medical Association, 2000-07, Vol.284 (2), p.183

2000

Volltextzugriff (PDF)

Effects of Antigen Dose and Immunization Regimens on Antibody Responses to a Cytomegalovirus Glycoprotein B Subunit Vaccine

The Journal of infectious diseases, 1999-11, Vol.180 (5), p.1700-1703

1999

Volltextzugriff (PDF)

A Human Immunodeficiency Virus Prime-Boost Immunization Regimen in Humans Induces Antibodies That Show Interclade Cross-Reactivity and Neutralize Several X4-, R5-, and Dualtropic Clade B and C Primary Isolates

Journal of Virology, 2000-11, Vol.74 (21), p.10025-10033

2000

Volltextzugriff (PDF)

Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus-Uninfected Recipients of Candidate AIDS Vaccines

The Journal of infectious diseases, 1997-04, Vol.175 (4), p.764-774

1997

Volltextzugriff (PDF)

Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine

The Lancet (British edition), 1993-07, Vol.342 (8863), p.69-73

1993

Volltextzugriff (PDF)

Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers

The Journal of infectious diseases, 2001-05, Vol.183 (9), p.1343-1352

2001

Volltextzugriff (PDF)

Mucosal Antibodies to Human Cytomegalovirus Glycoprotein B Occur following both Natural Infection and Immunization with Human Cytomegalovirus Vaccines

The Journal of infectious diseases, 1996-08, Vol.174 (2), p.387-392

1996

Volltextzugriff (PDF)

Effect of Previous or Simultaneous Immunization with Canarypox Expressing Cytomegalovirus (CMV) Glycoprotein B (gB) on Response to Subunit gB Vaccine plus MF59 in Healthy CMV-Seronegative Adults

The Journal of infectious diseases, 2002-03, Vol.185 (5), p.686-690

2002

Volltextzugriff (PDF)

Safety and Immunogenicity of Combinations of Recombinant Subtype E and B Human Immunodeficiency Virus Type 1 Envelope Glycoprotein 120 Vaccines in Healthy Thai Adults

The Journal of infectious diseases, 2003-07, Vol.188 (2), p.219-227

2003

Volltextzugriff (PDF)

Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial

The Journal of infectious diseases, 1995-05, Vol.171 (5), p.1343-1347

1995

Volltextzugriff (PDF)

Neutralization of Syncytium-Inducing Primary Isolates by Sera from Human Immunodeficiency Virus (HIV)-Uninfected Recipients of Candidate HIV Vaccines

The Journal of infectious diseases, 1998-11, Vol.178 (5), p.1502-1506

1998

Volltextzugriff (PDF)

Antibodies to the Major Linear Neutralizing Domains of Cytomegalovirus Glycoprotein B Among Natural Seropositives and CMV Subunit Vaccine Recipients

Viral immunology, 2000-01, Vol.13 (3), p.329-341

2000

Volltextzugriff (PDF)

Transport of recombinant human CD4-immunoglobulin G across the human placenta: pharmacokinetics and safety in six mother-infant pairs in AIDS clinical trial group protocol 146

Clinical and Diagnostic Laboratory Immunology, 1995-05, Vol.2 (3), p.281-285

1995

Volltextzugriff (PDF)

Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers

The Pediatric infectious disease journal, 2002-02, Vol.21 (2), p.133-138

2002

Volltextzugriff (PDF)

Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex

Journal of acquired immune deficiency syndromes and human retrovirology, 1995-10, Vol.10 (2), p.150-156

1995

Volltextzugriff (PDF)

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human Interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100–300 CD4 + t cells

Clinical immunology (Orlando, Fla.), 2003-03, Vol.106 (3), p.188-196

2003

Volltextzugriff (PDF)

A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group

AIDS research and human retroviruses, 2000-06, Vol.16 (9), p.907-919

2000

Volltextzugriff (PDF)

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences

Vaccine, 2000-02, Vol.18 (15), p.1448-1455

2000

Volltextzugriff (PDF)

Infection by hepatitis C virus in infants of HIV mothers. The HIV Infection in Newborn French Collaborative Study Group

Revue française de transfusion et d'hémobiologie, 1990-10, Vol.33 (5), p.339

1990

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(20)

Sprache

Englisch
(19)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Female
(16)
Male
(16)
Biological And Medical Sciences
(14)
Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Infectious Diseases
(13)
Middle Aged
(13)
Immunology
(12)
Aids/hiv
(10)
Aids Vaccines - Immunology
(9)
Antibodies
(9)
Medical Sciences
(9)
Vaccination
(9)
Adolescent
(8)
Hiv
(8)
Hiv Envelope Protein Gp120 - Immunology
(8)
Hiv-1 - Immunology
(8)
Microbiology
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant

Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial

Effects of Antigen Dose and Immunization Regimens on Antibody Responses to a Cytomegalovirus Glycoprotein B Subunit Vaccine

A Human Immunodeficiency Virus Prime-Boost Immunization Regimen in Humans Induces Antibodies That Show Interclade Cross-Reactivity and Neutralize Several X4-, R5-, and Dualtropic Clade B and C Primary Isolates

Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus-Uninfected Recipients of Candidate AIDS Vaccines

Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine

Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers

Mucosal Antibodies to Human Cytomegalovirus Glycoprotein B Occur following both Natural Infection and Immunization with Human Cytomegalovirus Vaccines

Effect of Previous or Simultaneous Immunization with Canarypox Expressing Cytomegalovirus (CMV) Glycoprotein B (gB) on Response to Subunit gB Vaccine plus MF59 in Healthy CMV-Seronegative Adults

Safety and Immunogenicity of Combinations of Recombinant Subtype E and B Human Immunodeficiency Virus Type 1 Envelope Glycoprotein 120 Vaccines in Healthy Thai Adults

Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial

Neutralization of Syncytium-Inducing Primary Isolates by Sera from Human Immunodeficiency Virus (HIV)-Uninfected Recipients of Candidate HIV Vaccines

Antibodies to the Major Linear Neutralizing Domains of Cytomegalovirus Glycoprotein B Among Natural Seropositives and CMV Subunit Vaccine Recipients

Transport of recombinant human CD4-immunoglobulin G across the human placenta: pharmacokinetics and safety in six mother-infant pairs in AIDS clinical trial group protocol 146

Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers

Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human Interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100–300 CD4 + t cells

A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences

Infection by hepatitis C virus in infants of HIV mothers. The HIV Infection in Newborn French Collaborative Study Group

Aktive Filter

Suchergebnisse filtern